Guild Learning and Development is partnering with Ego Pharmaceuticals in the development of an online course, “Quality use of topical corticosteroids in atopic dermatitis”
Atopic dermatitis affects up to 20% of children and 3% of adults worldwide, and according to the Global epidemiology and risk factors report, the incidence of this health condition in industrialised countries has increased two to three-fold during the past decade.
Being able to provide patients with medicines to treat this condition and ongoing support to maintain good skin health is key to engaging with patients and developing on-going engagement with them, the Guild says.
National President of the Pharmacy Guild of Australia, George Tambassis, said the course would provide community pharmacists with current best-practice guidelines for the use of topical corticosteroids.
“The term, ‘use sparingly’ is no longer widely used by GPs and dermatologists,” Mr Tambassis said.
“Community pharmacists can work with these health professionals and reinforce this message when speaking directly with their patients in the pharmacy.”
The new training module has been developed for pharmacists as part of the DERMIS educational program, in conjunction with the expert steering committee panel of Mr Tambassis, Clinical Associate Professor from University of Sydney Saxon Smith, and Dr Morton Rawlin.
Pharmacists who complete this course will be able to recognise the key issues around the use of topical corticosteroids, describe the recommendations for use, and outline the latest evidence on the safety and efficacy of topical corticosteroids.
The course will also assist pharmacists to implement an evidence-based approach to advising patients and carers about the practical use of topical corticosteroids in atopic dermatitis including the use of the “fingertip unit”.
This activity has been accredited for 1 hour of Group 1 CPD (or 1 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 1 hour of Group 2 CPD (or 2 CPD credits) upon successful completion of relevant assessment activities.
The Guild Learning and Development has thanked Ego Pharmaceuticals Pty Ltd for their financial support and input of expertise in the development of this course.